Design, development, and optimization of sumatriptan loaded ethosomal intra-nasal nanogel for brain targeting
Background: Sumatriptan is one of the most essential drugs for treating migraine. However, dosage-related side effects are still a worry despite its 14 % oral bioavailability and recurrence of migraine-associated diseases. Methodology: The fundamental focus of the study is to develop the sumatriptan...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Creative Pharma Assent,
2024-08-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|